Across TCGA pan-cancer cohorts, FAM32CP RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated FAM32CP data layer.
The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher FAM32CP RNA is associated with worse overall survival. In most high-consensus cancer types, elevated FAM32CP expression acts as an unfavorable survival marker, although some lineages such as COAD and LUAD show a favorable association.
BLCA, LIHC, and COAD are the cancer types where FAM32CP RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.